Intellectual Property
Jan. 14, 2014
California companies fight gene patent litigation
Utah-based Myriad Genetics Inc. has filed patent infringement claims in Utah against six competitors offering genetic tests for breast and ovarian cancer. Two California compaies are among the defendants.
Daily Journal Staff Writer
Up until last June, Myriad Genetics Inc. had been the sole provider of genetic diagnostic tests to determine risk factors for breast and ovarian cancer.
The Utah-based company had invested more than $500 million over the last two decades to create diagnostic tests to assess risk factors for breast and ovarian cancer, using patents related to the isolation and synthetic creation of certain human genes, ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In